Stephen Bartelmez

San Francisco, CA (USA)
Role(s):

BetaStem Therapeutics

Location: San Francisco
Industry: Bio-Technology
Year Founded: 2007
Number Employees: INVALID
Description: BetaStem Therapeutics is a privately held California corporation founded August 9th, 2006 by Stephen Bartelmez PhD, who has also provided initial funding. Teresa Ku PhD is a major shareholder, an expert in cellular diabetes treatment, and has been instrumental in shaping our diabetes program. We currently employ two people and have laboratory and executive office space in San Francisco. The company is in close proximity to academic institutions such as UC-San Francisco, UC-Berkeley and Stanford as well as highly successful biotech companies such as Genentech, Amgen, and FivePrime that are within easy collaborative distance from BetaStem. The company is developing stem cell therapy products based upon two robust IP-protected platforms. Our products in development are unique and not curr